RARA CRAFT DATABASE for FDA Medical Devices

FDA Device Decisions, June 2025: A Bone Graft That Beat Autograft in Lumbar Fusion, Sutureless Nerve Repair and Three De Novo Grants

日本語版

One of FDA's three original PMA approvals in June 2025 went to PearlMatrix Bone Graft (P240001), a bone graft for lumbar interbody fusion. In its pivotal trial, the composite clinical success rate at 24 months was not only non-inferior but superior to the control group, which used the patient's own bone (autograft).

Among the month's De Novo grants was a device for repairing a severed peripheral nerve without sutures, using a material that polymerizes in place around the nerve ends to join them.

Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 291 510(k)s in June 2025, granted 3 De Novo requests and approved 3 original PMAs. These counts have not been reconciled with FDA's own figures. The site holds 510(k), De Novo and PMA records from 2015 onward, and counts for past months can change as the data are updated.

Counts by pathway

June 2025 next to the previous month and the same month a year earlier, with records assigned to a month by FDA decision date.

PathwayJune 2025May 2025June 2024
510(k)291298256
De Novo343
PMA (original)332
PMA supplement216176169

Records held in RA Craft Database, decisions through August 31, 2026.

510(k) clearances were 7 fewer than in May but above June 2024 (256). There were 3 De Novo grants and 3 original PMAs.

The busiest product codes

June's 510(k)s spread across 187 product codes. GEX (powered laser surgical instrument) and QIH (automated radiological image processing software) led with 8 each, followed by DQY (catheter, percutaneous), HRS (plate, fixation, bone) and MAX (intervertebral fusion device with bone graft, lumbar) with 6 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions. If your code is on the list, enter it in the Product Code field on Search to see the records sorted by decision date.

De Novo: three classifications

June's three De Novo grants, all Class II, with the classification names and regulation numbers from each Classification Order:

  • APO-Easy Genotyping kit (DEN240032, Firalis SA): Neurologic disease predisposition risk assessment system (21 CFR 866.5850)
  • Oxiplex (DEN240038, FzioMed, Inc.): Absorbable gel for intraoperative use in spine surgery (21 CFR 888.3047)
  • COAPTIUM CONNECT with TISSIUM LIGHT (DEN240066, TISSIUM SA): In situ polymerizing peripheral nerve repair device (21 CFR 882.5270)

"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.

Oxiplex is an absorbable gel used in lumbar discectomy in adults with leg pain, back pain and neurological symptoms, to reduce leg pain and neurological symptoms. Clinical performance data is one of its special controls.

Original PMAs: three approvals

  • Neuspera Sacral Neuromodulation System (P240031, Neuspera Medical Inc): a wirelessly powered sacral neuromodulation system for the symptoms of urinary urge incontinence (product code EZW)
  • PearlMatrix Bone Graft (P240001, Cerapedics, Inc.): a P-15 peptide bone graft for lumbar interbody fusion (NOX)
  • CGuard Prime Carotid Stent System (P240029, InspireMD, Ltd.): a nitinol carotid stent covered with polyethylene terephthalate (PET) mesh (NIM)

June also brought 216 PMA supplements, which cover changes to already approved PMA devices among other things.

Three devices worth a closer read

1. PearlMatrix Bone Graft (P240001, PMA). Synthetic P-15 peptide on porcine anorganic bone mineral particles, held in a bovine collagen carrier. It is used at one level from L2 to S1 for degenerative disc disease with up to Grade I spondylolisthesis, with a PEEK (polyether ether ketone) device for transforaminal lumbar interbody fusion (TLIF) and supplemental spinal fixation. The ASPIRE trial was a single-blinded randomized trial at 33 sites; composite clinical success at 24 months was 55.4% with PearlMatrix and 36.4% with autograft. According to the Summary of Safety and Effectiveness Data (SSED) that FDA published with the approval, the device received Breakthrough Device designation in April 2021.

2. COAPTIUM CONNECT with TISSIUM LIGHT (DEN240066, De Novo). For sutureless repair of peripheral nerve injuries with a gap of 1 cm or less, or one that can be brought to 1 cm or less by flexing the limb. As the classification name says, it uses a material that polymerizes in place. Its eight special controls include testing in a clinically relevant animal model, characterization of the polymerization process, mechanical and other testing of the polymerized device, human factors and usability testing, and biocompatibility that covers precursors and degradants.

3. APO-Easy Genotyping kit (DEN240032, De Novo). A PCR test that detects two single nucleotide polymorphisms in the APOE gene from blood DNA. Used with other laboratory and clinical information, it aids in evaluating the risk of late-onset Alzheimer's disease in patients with cognitive impairment who are being evaluated for Alzheimer's and other causes of cognitive decline. The special controls require labeling stating that the test is not a screening or diagnostic test and does not determine overall disease risk.

Compare the three devices

Open P240001, DEN240066 and DEN240032, star (☆) each one, tick "Compare" on all three in My Workspace and press "3 selected for comparison". The comparison table puts their Indications for Use side by side. Before relying on any of this, open "FDA Record" and "Summary PDF" on each record and read the source.

Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles